Nicox S.A.
COX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013018124 (+6 more)
- LEI:
- 969500EZGEO9W4JXR353
- Country:
- France
- Address:
- SOPHIA, 06410 BIOT
- Website:
- https://www.nicox.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Developing innovative ocular solutions Nicox is an international ophthalmology company developing innovative therapeutics to help maintain vision and improve ocular health. We plan to keep the maximum of options open for the company by maintaining rights to our novel therapeutics for eye diseases in key territories, such as the U.S. and Europe, as we create value by advancing their development, maintaining the potential for direct marketing, licensing for certain territories and growth through strategic transactions. We are focused on the discovery, development and commercialization of novel ophthalmic therapeutics for eye diseases.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 07:30 |
Capital/Financing Update
Nicox Extends Existing Flexible Equity Financing
|
English | 181.9 KB | |
| 2025-08-05 07:30 |
Regulatory News Service
Nicox annonce l’initiation par son partenaire Kowa d’un essai clinique de Phase…
|
French | 176.0 KB | |
| 2025-08-05 07:30 |
Regulatory News Service
Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan
|
English | 171.5 KB | |
| 2025-06-30 07:30 |
Regulatory News Service
Nicox annonce que le dernier patient a terminé l’essai clinique de Phase 3 Dena…
|
French | 161.2 KB | |
| 2025-06-30 07:30 |
Inside Information Statement
Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial
|
English | 156.1 KB | |
| 2025-06-06 07:30 |
General Meeting Notice
Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 27 ju…
|
French | 184.6 KB | |
| 2025-06-06 07:30 |
General Meeting Notice
Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 2…
|
English | 175.2 KB | |
| 2025-05-27 07:30 |
Regulatory News Service
Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX…
|
English | 179.6 KB | |
| 2025-05-27 07:30 |
Regulatory News Service
Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Ko…
|
French | 183.6 KB | |
| 2025-05-14 07:30 |
Earnings Release
Nicox annonce les résultats de l’étude exploratoire de phase 3b Whistler dans l…
|
French | 199.5 KB | |
| 2025-05-14 07:30 |
Earnings Release
Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
|
English | 184.4 KB | |
| 2025-04-30 07:30 |
Earnings Release
Nicox Provides Full Year 2024 Financial Results
|
English | 181.9 KB | |
| 2025-04-30 07:30 |
Earnings Release
Nicox : Résultats financiers de l’année 2024
|
French | 180.4 KB | |
| 2025-03-19 07:30 |
Inside Information Statement
Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler…
|
English | 218.6 KB | |
| 2025-03-19 07:30 |
Regulatory News Service
Nicoxannonce que la visite finale du dernier patient a été effectuée dans l’étu…
|
French | 237.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |